Ageing or cancer: a review on the role of caretakers and gatekeepers.

Ageing is due to the accumulation of damage, which arises because of evolved limitations in mechanisms for maintenance and repair. Accumulated damage may cause genomic instability, which in organisms with renewable tissues may result in cancer. To keep cancer at bay, two different tumour suppression mechanisms evolved: caretakers and gatekeepers. Caretakers protect the genome against mutations, while gatekeepers induce cell death or cell cycle arrest of potentially tumourigenic cells. It has been hypothesised that decreased activity of a caretaker may reduce life span, by increasing cancer risk, while the effects of increased activity of a gatekeeper on cancer risk and life span may be antagonistically pleiotropic. Apoptosis and senescence will promote early-life survival by curtailing the development of cancer, but may eventually limit longevity. This article reviews the evidence for this hypothesis. We conclude that several different findings indeed hint at an important role for gatekeeper mediated processes in ageing and its related pathologies. The relative contribution of apoptosis and senescence in specific age-related pathologies remains to be established.

[1]  F. Malisan,et al.  Differential regulation of apoptotic cell death in senescent human cells , 2004, Experimental Gerontology.

[2]  R. Hoover,et al.  Determination of the allelic frequencies of an L-myc and a p53 polymorphism in human lung cancer. , 1994, Carcinogenesis.

[3]  Senescence and Death of Primitive Cells and Myocytes Lead to Premature Cardiac Aging and Heart Failure , 2003 .

[4]  G. van Zant,et al.  The role of stem cells in aging. , 2003, Experimental hematology.

[5]  Z. Darżynkiewicz,et al.  Telomere shortening is an in vivo marker of myocyte replication and aging. , 2000, The American journal of pathology.

[6]  J. Hoeijmakers,et al.  Nucleotide Excision Repair Disorders and the Balance Between Cancer and Aging , 2006, Cell cycle.

[7]  J. Campisi.  Senescent Cells, Tumor Suppression, and Organismal Aging: Good Citizens, Bad Neighbors , 2005, Cell.

[8]  J. Carrington.  Aging bone and cartilage: cross-cutting issues. , 2005, Biochemical and biophysical research communications.

[9]  S. Gupta,et al.  Molecular and biochemical pathways of apoptosis in lymphocytes from aged humans. , 2000, Vaccine.

[10]  M. Murphy,et al.  The codon 72 polymorphic variants of p53 have markedly different apoptotic potential , 2003, Nature Genetics.

[11]  C. Leeuwenburgh,et al.  Muscle fiber‐specific apoptosis and TNF‐α signaling in sarcopenia are attenuated by life‐long calorie restriction , 2005, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[12]  N. Sharpless.  Ink4a/Arf links senescence and aging , 2004, Experimental Gerontology.

[13]  J. Marx.  How p53 suppresses cell growth. , 1993, Science.

[14]  Margaret Ashcroft,et al.  Regulation of p53 stability , 1999, Oncogene.

[15]  H. Dvorak,et al.  Differential expression of thymosin β‐10 by early passage and senescent vascular endothelium is modulated by VPF/VEGF: evidence for senescent endothelial cells in vivo at sites of atherosclerosis , 2001, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[16]  I. Irminger-Finger,et al.  Science of cancer and aging. , 2007, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[17]  Pascal Meier,et al.  Apoptosis in development , 2000, Nature.

[18]  C. Leeuwenburgh,et al.  The Role of Apoptosis in the Normal Aging Brain, Skeletal Muscle, and Heart , 2002, Annals of the New York Academy of Sciences.

[19]  Matthias Platzer,et al.  Nibrin, a Novel DNA Double-Strand Break Repair Protein, Is Mutated in Nijmegen Breakage Syndrome , 1998, Cell.

[20]  D. van Heemst,et al.  End-joining of blunt DNA double-strand breaks in mammalian fibroblasts is precise and requires DNA-PK and XRCC4. , 2004, DNA repair.

[21]  Bert Vogelstein,et al.  Gatekeepers and caretakers , 1997, Nature.

[22]  E. Wang,et al.  Senescent fibroblasts resist apoptosis by downregulating caspase-3 , 2004, Mechanisms of Ageing and Development.

[23]  C. Franceschi,et al.  p53 Codon 72 Alleles Influence the Response to Anticancer Drugs in Cells from Aged People by Regulating the Cell Cycle Inhibitor p21WAF1 , 2005, Cell cycle.

[24]  Martin Schuler,et al.  Direct Activation of Bax by p53 Mediates Mitochondrial Membrane Permeabilization and Apoptosis , 2004, Science.

[25]  J. Nevins,et al.  E2F: a link between the Rb tumor suppressor protein and viral oncoproteins. , 1992, Science.

[26]  O. Pereira-smith,et al.  Replicative Senescence: Implications for in Vivo Aging and Tumor Suppression , 1996, Science.

[27]  V. Paradis,et al.  Replicative senescence in normal liver, chronic hepatitis C, and hepatocellular carcinomas. , 2001, Human pathology.

[28]  V. Dulic,et al.  Differential Roles for Cyclin-Dependent Kinase Inhibitors p21 and p16 in the Mechanisms of Senescence and Differentiation in Human Fibroblasts , 1999, Molecular and Cellular Biology.

[29]  M. Herman,et al.  Age-related hippocampal changes in Bcl-2:Bax ratio, oxidative stress, redox-active iron and apoptosis associated with aluminum-induced neurodegeneration: increased susceptibility with aging. , 1999, Neurotoxicology.

[30]  D. Hanahan,et al.  The Hallmarks of Cancer , 2000, Cell.

[31]  D. Lane,et al.  Transcription — guarding the genome by sensing DNA damage , 2004, Nature Reviews Cancer.

[32]  D. Fisher,et al.  Mechanisms of Hair Graying: Incomplete Melanocyte Stem Cell Maintenance in the Niche , 2005, Science.

[33]  R. Fleischmann,et al.  Mutations of two P/WS homologues in hereditary nonpolyposis colon cancer , 1994, Nature.

[34]  H. Gertz,et al.  Aberrant expression of nNOS in pyramidal neurons in Alzheimer's disease is highly co-localized with p21ras and p16INK4a , 2000, Brain Research.

[35]  Judith Campisi,et al.  Cancer and ageing: rival demons? , 2003, Nature Reviews Cancer.

[36]  U. Gärtner,et al.  Expression of the cyclin‐dependent kinase inhibitor p16 in Alzheimer's disease , 1996, Neuroreport.

[37]  C. Harley,et al.  Telomerase expression restores dermal integrity to in vitro-aged fibroblasts in a reconstituted skin model. , 2000, Experimental cell research.

[38]  W. Horton,et al.  Chondrocyte apoptosis in development, aging and disease. , 1998, Matrix biology : journal of the International Society for Matrix Biology.

[39]  L. Donehower.  Does p53 affect organismal aging? , 2002, Journal of cellular physiology.

[40]  V. Rotter,et al.  Change of the Death Pathway in Senescent Human Fibroblasts in Response to DNA Damage Is Caused by an Inability To Stabilize p53 , 2001, Molecular and Cellular Biology.

[41]  A. Salmon,et al.  Multiplex stress resistance in cells from long‐lived dwarf mice , 2003, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[42]  Robin J. Leach,et al.  Mutations of a mutS homolog in hereditary nonpolyposis colorectal cancer , 1993, Cell.

[43]  Charles J. Sherr,et al.  Nucleolar Arf sequesters Mdm2 and activates p53 , 1999, Nature Cell Biology.

[44]  C Roskelley,et al.  A biomarker that identifies senescent human cells in culture and in aging skin in vivo. , 1995, Proceedings of the National Academy of Sciences of the United States of America.

[45]  Robert W. Miller,et al.  Mutations in RECQL4 cause a subset of cases of Rothmund-Thomson syndrome , 1999, Nature Genetics.

[46]  Ching-Wei Chang,et al.  Transcription inhibition: a potential strategy for cancer therapeutics. , 2005, European journal of cancer.

[47]  Xiaoling Zhang,et al.  The ATM/p53/p21 Pathway Influences Cell Fate Decision between Apoptosis and Senescence in Reoxygenated Hematopoietic Progenitor Cells* , 2005, Journal of Biological Chemistry.

[48]  K. Mohammad,et al.  Modulation of mammalian life span by the short isoform of p53. , 2004, Genes & development.

[49]  J. Hoeijmakers,et al.  Nucleotide excision repair and human syndromes. , 2000, Carcinogenesis.

[50]  M. Janssen-Heijnen,et al.  Comprehensive geriatric assessment and its clinical impact in oncology. , 2007, European journal of cancer.

[51]  S. Maddika,et al.  Cell survival, cell death and cell cycle pathways are interconnected: implications for cancer therapy. , 2007, Drug resistance updates : reviews and commentaries in antimicrobial and anticancer chemotherapy.

[52]  R. Fleischmann,et al.  Mutation of a mutL homolog in hereditary colon cancer. , 1994, Science.

[53]  George C. Williams,et al.  PLEIOTROPY, NATURAL SELECTION, AND THE EVOLUTION OF SENESCENCE , 1957, Science of Aging Knowledge Environment.

[54]  T. Kirkwood,et al.  Positive correlation between mammalian life span and cellular resistance to stress. , 1999, Free radical biology & medicine.

[55]  S. Elledge,et al.  Cancer: p53 sends nucleotides to repair DNA , 2000, Nature.

[56]  K. Nakayama,et al.  Mice lacking a CDK inhibitor, p57Kip2, exhibit skeletal abnormalities and growth retardation. , 2000, Journal of biochemistry.

[57]  A. Levine,et al.  Surfing the p53 network , 2000, Nature.

[58]  M. Roussel,et al.  Cooperative Signals Governing ARF-Mdm2 Interaction and Nucleolar Localization of the Complex , 2000, Molecular and Cellular Biology.

[59]  N. Ellis,et al.  The Bloom's syndrome gene product is homologous to RecQ helicases , 1995, Cell.

[60]  D. Quaglino,et al.  Cell proliferation and apoptosis in the immune system in the elderly , 2000, Immunologic research.

[61]  In-Hwan Song,et al.  Exploration of replicative senescence-associated genes in human dermal fibroblasts by cDNA microarray technology , 2004, Experimental Gerontology.

[62]  J. Hoeijmakers,et al.  Fanconi Anemia (Cross)linked to DNA Repair , 2005, Cell.

[63]  M. Memo,et al.  The different apoptotic potential of the p53 codon 72 alleles increases with age and modulates in vivo ischaemia-induced cell death , 2004, Cell Death and Differentiation.

[64]  G. Hannon,et al.  Involvement of the cyclin-dependent kinase inhibitor p16 (INK4a) in replicative senescence of normal human fibroblasts. , 1996, Proceedings of the National Academy of Sciences of the United States of America.

[65]  S. Gollapudi,et al.  Functional Decline in Aging and Disease: A Role for Apoptosis , 2001, Journal of the American Geriatrics Society.

[66]  N. Sharpless,et al.  Ink4a/Arf expression is a biomarker of aging. , 2004, The Journal of clinical investigation.

[67]  G. Stein,et al.  Origins of G1 arrest in senescent human fibroblasts , 1995, BioEssays : news and reviews in molecular, cellular and developmental biology.

[68]  G. Azhar,et al.  Bcl-2 and Bax expression in adult rat hearts after coronary occlusion: age-associated differences. , 1998, American journal of physiology. Regulatory, integrative and comparative physiology.

[69]  J. Hoeijmakers.  Genome maintenance mechanisms for preventing cancer , 2001, Nature.

[70]  I. Hickson,et al.  Caretaker tumour suppressor genes that defend genome integrity. , 2002, Trends in molecular medicine.

[71]  L. Donehower,et al.  Mice deficient for p53 are developmentally normal but susceptible to spontaneous tumours , 1992, Nature.

[72]  K. Cerosaletti,et al.  A patient with mutations in DNA Ligase IV: Clinical features and overlap with Nijmegen breakage syndrome , 2005, American journal of medical genetics. Part A.

[73]  P. Klatt,et al.  'Super p53' mice exhibit enhanced DNA damage response, are tumor resistant and age normally , 2002, The EMBO journal.

[74]  M. Smith,et al.  Abnormal expression of the cell cycle regulators P16 and CDK4 in Alzheimer's disease. , 1997, The American journal of pathology.

[75]  Jia-qing Li,et al.  Loss of p57KIP2 is associated with colorectal carcinogenesis. , 2003, International journal of oncology.

[76]  I. Weissman,et al.  Rejuvenation of aged progenitor cells by exposure to a young systemic environment , 2005, Nature.

[77]  T. Crook,et al.  Polymorphism in wild-type p53 modulates response to chemotherapy in vitro and in vivo , 2004, Oncogene.

[78]  L. Strong,et al.  Germ line p53 mutations in a familial syndrome of breast cancer, sarcomas, and other neoplasms. , 1990, Science.

[79]  G. Schellenberg,et al.  Positional Cloning of the Werner's Syndrome Gene , 1996, Science.

[80]  Y. Higami,et al.  Apoptosis in the aging process , 2000, Cell and Tissue Research.

[81]  Philip D. Jeffrey,et al.  Structural basis for inhibition of the cyclin-dependent kinase Cdk6 by the tumour suppressor p16INK4a , 1998, Nature.

[82]  M. Gosney.  Contribution of the geriatrician to the management of cancer in older patients. , 2007, European journal of cancer.

[83]  J. Campisi,et al.  Cancer and aging: a model for the cancer promoting effects of the aging stroma. , 2002, The international journal of biochemistry & cell biology.

[84]  J. Hoeijmakers,et al.  DNA repair mechanisms. , 2001, Maturitas.

[85]  J. Trent,et al.  WAF1, a potential mediator of p53 tumor suppression , 1993, Cell.

[86]  Bernd W. Brandt,et al.  Variation in the human TP53 gene affects old age survival and cancer mortality1 , 2005, Experimental Gerontology.

[87]  J Chang-Claude,et al.  Genetic heterogeneity and penetrance analysis of the BRCA1 and BRCA2 genes in breast cancer families. The Breast Cancer Linkage Consortium. , 1998, American journal of human genetics.

[88]  Mammalian nucleotide excision repair and syndromes. , 1997, Biochemical Society transactions.

[89]  I. Weissman,et al.  Stem cells, cancer, and cancer stem cells , 2001, Nature.

[90]  D. Pim,et al.  p53 polymorphic variants at codon 72 exert different effects on cell cycle progression , 2004, International journal of cancer.

[91]  J C Reed,et al.  Mitochondria and apoptosis. , 1998, Science.

[92]  C. Franceschi,et al.  What studies on human longevity tell us about the risk for cancer in the oldest old: data and hypotheses on the genetics and immunology of centenarians , 2002, Experimental Gerontology.

[93]  S. Lowe,et al.  Control of apoptosis by p53 , 2003, Oncogene.

[94]  M. Lovett,et al.  A single ataxia telangiectasia gene with a product similar to PI-3 kinase. , 1995, Science.

[95]  Stephen N. Jones,et al.  p53 mutant mice that display early ageing-associated phenotypes , 2002, Nature.

[96]  W. Horton,et al.  Age-related expression patterns of Bag-1 and Bcl-2 in growth plate and articular chondrocytes. , 2004, The anatomical record. Part A, Discoveries in molecular, cellular, and evolutionary biology.